Biomimetic nanoparticles with enhanced rapamycin delivery for autism spectrum disorder treatment via autophagy activation and oxidative stress modulation
Chenlin Miao, Yizhe Shen, Yue Lang, Hui Li, Yan Gong, Yamei Liu, Huafei Li, Byron C. Jones, Fuxue Chen, Shini Feng
Abstract
The therapeutic potential of SCM@RAPA in managing ASD signifies a paradigm shift in autism drug treatment, holding promise for clinical interventions in diverse neurological conditions.
Topics & Concepts
AutophagyOxidative stressAutismDrug deliveryPI3K/AKT/mTOR pathwayPharmacologyMedicineNeuroscienceBiologyCell biologySignal transductionMaterials scienceApoptosisNanotechnologyPsychiatryBiochemistryAdenosine and Purinergic SignalingExtracellular vesicles in diseaseRNA Interference and Gene Delivery